SHILPAMED Financial Statements

SHILPAMED Annual Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (0.70) 15.10 1.24 8.76
Op profit growth (17) 35.50 (5.30) 7.06
EBIT growth (18) 31.60 (8.50) 9.26
Net profit growth (5.40) 48.40 (2.20) (0.70)
Profitability ratios (%)        
OPM 20.20 24.20 20.60 22
EBIT margin 17.50 21.30 18.60 20.60
Net profit margin 16.40 17.20 13.30 13.80
RoCE 7.45 12.10 10.90 14.10
RoNW 2.63 3.23 2.54 3.29
RoA 1.74 2.45 1.96 2.37
Per share ratios ()        
EPS 17.90 19 12.60 13
Dividend per share 1.10 1.10 0.70 0.60
Cash EPS 11.50 13.80 8.34 9.60
Book value per share 181 163 133 123
Valuation ratios        
P/E 18.60 12.90 36.80 48.80
P/CEPS 29 17.70 55.70 66.20
P/B 1.84 1.50 3.49 5.16
EV/EBIDTA 16.30 9.88 21.30 27.40
Payout (%)        
Dividend payout -- -- 6.53 5.38
Tax payout (36) (18) (24) (27)
Liquidity ratios        
Debtor days 95.10 93.90 90.50 59.80
Inventory days 110 83.40 87.60 82.60
Creditor days (61) (63) (65) (64)
Leverage ratios        
Interest coverage (7.20) (42) (55) (51)
Net debt / equity 0.49 0.26 0.11 0.14
Net debt / op. profit 3.97 1.57 0.72 0.82
Cost breakup ()        
Material costs (30) (31) (45) (48)
Employee costs (26) (22) (19) (16)
Other costs (24) (24) (15) (14)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 901 908 789 779
yoy growth (%) (0.70) 15.10 1.24 8.76
Raw materials (271) (278) (356) (372)
As % of sales 30 30.60 45.10 47.70
Employee costs (235) (197) (149) (128)
As % of sales 26.10 21.70 18.90 16.40
Other costs (213) (214) (122) (108)
As % of sales 23.70 23.50 15.40 13.90
Operating profit 182 220 162 171
OPM 20.20 24.20 20.60 22
Depreciation (54) (44) (37) (31)
Interest expense (22) (4.60) (2.70) (3.10)
Other income 30.10 16.90 21.70 19.70
Profit before tax 136 188 144 157
Taxes (49) (33) (34) (42)
Tax rate (36) (18) (24) (27)
Minorities and other 1.58 1.59 2.38 3.12
Adj. profit 88.70 157 112 118
Exceptional items 60.80 -- -- (4.50)
Net profit 148 156 105 108
yoy growth (%) (5.40) 48.40 (2.20) (0.70)
NPM 16.40 17.20 13.30 13.80
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 136 188 144 157
Depreciation (54) (44) (37) (31)
Tax paid (49) (33) (34) (42)
Working capital 572 278 245 --
Other operating items -- -- -- --
Operating cashflow 605 390 318 84.50
Capital expenditure 973 510 18.30 --
Free cash flow 1,578 899 336 84.50
Equity raised 1,713 1,705 1,618 1,856
Investments 10.90 (55) 87.40 --
Debt financing/disposal 827 264 49.20 15.70
Dividends paid -- -- 6.87 5.79
Other items -- -- -- --
Net in cash 4,129 2,813 2,098 1,962
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 8.15 8.15 8.15 8.15
Preference capital -- -- -- --
Reserves 1,471 1,321 1,189 1,077
Net worth 1,479 1,329 1,198 1,085
Minority interest
Debt 844 390 194 191
Deferred tax liabilities (net) 112 101 101 97
Total liabilities 2,424 1,813 1,485 1,368
Fixed assets 1,652 1,317 987 744
Intangible assets
Investments 21.20 10.50 2.26 140
Deferred tax asset (net) 64.80 59.20 53.50 37.70
Net working capital 563 382 348 372
Inventories 317 226 188 189
Inventory Days 128 91 -- 87.30
Sundry debtors 223 247 204 220
Debtor days 90.20 99.20 -- 102
Other current assets 302 144 135 132
Sundry creditors (114) (127) (100) (110)
Creditor days 46 50.90 -- 50.90
Other current liabilities (165) (109) (78) (59)
Cash 123 44.60 94.50 73.80
Total assets 2,424 1,813 1,485 1,368
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Mar-2021 Mar-2020 Mar-2019 Mar-2018
Gross Sales 1,146 901 908 733 792
Excise Duty -- -- -- -- 2.71
Net Sales 1,146 901 908 733 789
Other Operating Income -- -- -- -- --
Other Income 23 91 16.90 33.60 21.70
Total Income 1,169 992 925 767 811
Total Expenditure ** 945 721 688 586 634
PBIDT 223 271 236 181 177
Interest 41.20 21.90 4.56 3.68 2.66
PBDT 182 249 232 178 174
Depreciation 79.80 54 43.80 42.10 37.20
Minority Interest Before NP -- -- -- -- --
Tax 34 45.20 39.90 37.90 35
Deferred Tax 7.64 3.62 (6.40) (12) (1.10)
Reported Profit After Tax 60.60 146 155 110 103
Minority Interest After NP (0.10) (1.60) (1.60) (2.80) (2.40)
Net Profit after Minority Interest 60.70 148 156 112 105
Extra-ordinary Items 5.21 45.60 -- 14.30 --
Adjusted Profit After Extra-ordinary item 55.50 102 156 97.90 105
EPS (Unit Curr.) 7.26 18.10 19.20 13.80 12.90
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) 110 110 110 100 70
Equity 8.68 8.15 8.15 8.15 8.15
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 19.50 30.10 26 24.70 22.40
PBDTM(%) 15.90 27.60 25.50 24.20 22.10
PATM(%) 5.29 16.20 17 14.90 13
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity